Literature DB >> 21160637

Goblet cell carcinoid tumors of the appendix: An overview.

Paromita Roy1, Runjan Chetty.   

Abstract

Goblet cell carcinoid is an enigmatic and rare tumor involving the appendix almost exclusively. Since its identification in 1969, understanding of this disease has evolved greatly, but issues regarding its histogenesis, nomenclature and management are still conjectural. The published English language literature from 1966 to 2009 was retrieved via PubMed and reviewed. Various other names have been used for this entity such as adenocarcinoid, mucinous carcinoid, crypt cell carcinoma, and mucin-producing neuroendocrine tumor, although none have been found to be completely satisfactory or universally accepted. The tumor is thought to arise from pluripotent intestinal epithelial crypt-base stem cells by dual neuroendocrine and mucinous differentiation. GCCs present in the fifth to sixth decade and show no definite sex predominance. The most common clinical presentation is acute appendicitis, followed by abdominal pain and a mass. Fifty percent of the female patients present with ovarian metastases. The histologic hallmark of this entity is the presence of clusters of goblet cells in the lamina propria or submucosa stain for various neuroendocrine markers, though the intensity is often patchy. Atypia is usually minimal, but carcinomatous growth patterns may be seen. These may be of signet ring cell type or poorly differentiated adenocarcinoma. Recently molecular studies have shown these tumors to lack the signatures of adenocarcinoma but they have some changes similar to that of ileal carcinoids (allelic loss of chromosome 11q, 16q and 18q). The natural history of GCC is intermediate between carcinoids and adenocarcinomas of the appendix. The 5-year overall survival is 76%. The most important prognostic factor is the stage of disease. Appendectomy and right hemicolectomy are the main modalities of treatment, followed by adjuvant chemotherapy in select cases. There is some debate about the surgical approach for these tumors, and a summary of published series and recommendations are provided.

Entities:  

Keywords:  Appendiceal neoplasm; Goblet cell carcinoid; Mucin-producing neuroendocrine tumor of appendix

Year:  2010        PMID: 21160637      PMCID: PMC2998842          DOI: 10.4251/wjgo.v2.i6.251

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  42 in total

1.  Expression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation.

Authors:  Chiun Chei Li; Mitsuyoshi Hirowaka; Zhi Rong Qian; Bing Xu; Toshiaki Sano
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998.

Authors:  Margaret E McCusker; Timothy R Coté; Limin X Clegg; Leslie H Sobin
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

3.  Management of goblet cell carcinoid.

Authors:  John C Byrn; Ju-Lin Wang; Celia M Divino; Scott Q Nguyen; Richard R P Warner
Journal:  J Surg Oncol       Date:  2006-10-01       Impact factor: 3.454

4.  Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.

Authors:  Mirela Stancu; Tsung-Teh Wu; Charita Wallace; Patrick S Houlihan; Stanley R Hamilton; Asif Rashid
Journal:  Mod Pathol       Date:  2003-12       Impact factor: 7.842

5.  Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases.

Authors:  R L Warkel; P H Cooper; E B Helwig
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

6.  The amphicrine (endo-exocrine) cells in the human gut, with a short reference to amphicrine neoplasias.

Authors:  M Ratzenhofer; L Auböck
Journal:  Acta Morphol Acad Sci Hung       Date:  1980

7.  Adenocarcinoid of the vermiform appendix.

Authors:  B Olsson; O Ljungberg
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  CK19 and CD99 immunoexpression profile in goblet cell (mucin-producing neuroendocrine tumors) and classical carcinoids of the vermiform appendix.

Authors:  Khaled O Alsaad; Stefano Serra; Aurel Perren; Eugene Hsieh; Runjan Chetty
Journal:  Int J Surg Pathol       Date:  2007-07       Impact factor: 1.271

9.  Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor).

Authors:  P Isaacson
Journal:  Am J Surg Pathol       Date:  1981-04       Impact factor: 6.394

10.  Goblet cell carcinoid of the appendix.

Authors:  Payam S Pahlavan; Rani Kanthan
Journal:  World J Surg Oncol       Date:  2005-06-20       Impact factor: 2.754

View more
  32 in total

Review 1.  [Surgical strategies for accidental detection of appendix carcinoids].

Authors:  H Dralle
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

2.  Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity.

Authors:  Shayna Brathwaite; Jonathan Rock; Martha M Yearsley; Tanios Bekaii-Saab; Lai Wei; Wendy L Frankel; John Hays; Christina Wu; Sherif Abdel-Misih
Journal:  Ann Surg Oncol       Date:  2016-03-10       Impact factor: 5.344

3.  Molecular Characterization of Appendiceal Goblet Cell Carcinoid.

Authors:  Hiroyuki Arai; Yasmine Baca; Francesca Battaglin; Natsuko Kawanishi; Jingyuan Wang; Shivani Soni; Wu Zhang; Joshua Millstein; Curtis Johnston; Richard M Goldberg; Philip A Philip; Andreas Seeber; Joanne Xiu; Jimmy J Hwang; Anthony F Shields; John L Marshall; W Michael Korn; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2020-10-09       Impact factor: 6.261

Review 4.  [Rectal goblet cell carcinoid. Primary tumor or metastasis?].

Authors:  K Krümpelmann; T Hansen; W Fried-Proell; M Habekost; D Flieger; S Sommer; C J Kirkpatrick
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

5.  Appendiceal goblet cell carcinomas have poor survival despite completion surgery.

Authors:  Edward Alabraba; David Mark Pritchard; Rebecca Griffin; Rafael Diaz-Nieto; Melissa Banks; Daniel James Cuthbertson; Stephen Fenwick
Journal:  Endocrine       Date:  2021-04-23       Impact factor: 3.633

6.  Appendiceal goblet cell adenocarcinoma with peritoneal recurrence 9 years after surgery.

Authors:  Masato Tamiya; Kenji Matsuda; Hiromitsu Iwamoto; Yasuyuki Mitani; Yuki Mizumoto; Yuki Nakamura; Toshihiro Sakanaka; Norio Takemoto; Takahiko Hyo; Ryuta Iwamoto; Hiroki Yamaue
Journal:  Int Cancer Conf J       Date:  2021-10-27

Review 7.  Appendiceal Neoplasms.

Authors:  Quinton M Hatch; Erin W Gilbert
Journal:  Clin Colon Rectal Surg       Date:  2018-09-04

8.  Goblet cell carcinoid of the appendix accompanied by adenomatous polyp with high-grade dysplasia at the cecum.

Authors:  İbrahim Ali Özemir; Hakan Baysal; Ebru Zemheri; Çağrı Bilgiç; Rafet Yiğitbaşı; Orhan Alimoğlu
Journal:  Turk J Surg       Date:  2018-01-03

9.  Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile and predictors.

Authors:  Chibueze Onyemkpa; Alan Davis; Michael McLeod; Tolutope Oyasiji
Journal:  J Gastrointest Oncol       Date:  2019-04

10.  Clinicopathologic and prognostic features in appendiceal malignancies: does tumor invasiveness matter?

Authors:  Kazım Şenol; Murat Ferhat Ferhatoğlu; Deniz Tihan
Journal:  Turk J Surg       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.